News
Boehringer Ingelheim & LEO Pharma partner to commercialize and further develop Spevigo: Ingelheim, Germany Wednesday, July 16, 2025, 15:00 Hrs [IST] Boehringer Ingelheim, a biopha ...
Boehringer Ingelheim set to receive EUR 90 million as upfront payment, along with milestone payments and tiered royalties.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback